Nepalese traditional medicine and symptoms related to Parkinson׳s disease and other disorders: Patterns of the usage of plant resources along the Himalayan altitudinal range

https://doi.org/10.1016/j.jep.2014.02.016Get rights and content

Abstract

Ethnopharmacological relevance

Nepal is a hotspot for cultural and biological diversities. The tremendous diversity of ecosystems and climates and the blend of medicinal practices inherited from Ayurvedic and Traditional Tibetan Medicine are well suited to a study aimed at discovering information about medicinal plants to treat Parkinson’s disease (PD). In addition, this study across Nepal’s altitudinal range is relevant to understanding how cultural and ecological environments influence local traditional medicines. The aim of the study is to document the uses of medicinal plants in three different eco-geographical areas of Nepal (Chitwan–Panchase–Mustang) to treat symptoms related to PD. A second goal is to analyze the impact of culture and environment on the evolution of traditional medicine.

Materials and methods

The study was conducted in five communities located in three different eco-geographical environments and at altitudes ranging from 300 m to 3700 m. We interviewed a total of 56 participants (local people, folk, Ayurvedic and Amchi healers) across the three research areas. We conducted open-ended interviews to document the uses of medicinal plants to treat PD-related symptoms. Information provided by the interviewees suggested that the medicinal plants are also used to treat symptoms related to other disorders. We determined the informant consensus factor as well as the importance of specific plant species to (i) identify plants that are the best candidates to be analyzed experimentally for their potential to treat PD and (ii) perform a cross-cultural comparison of the three areas of study.

Results

This study reports the local uses of 35 different plant species along the Chitwan–Panchase–Mustang altitudinal range. We identify a total of eight plant species that were used in all three research areas, and more specifically one species used to treat PD-like symptoms. We identify a potential dual protective activity of medicinal plants used to treat PD-related symptoms as recent literature suggests that these plants also have anti-cancer properties. In addition, we document that the presence of Ayurvedic healers could influence local practices and that local practices could influence local Ayurvedic practices.

Conclusions

This study documents the uses of medicinal plants to treat symptoms related to PD and other disorders across the Chitwan–Panchase–Mustang altitudinal range. PD is a neurodegenerative disease affecting a growing number of people worldwide. No cures are available to slow the death of the neurons, and there is a critical need to work towards innovative therapeutic strategies. We identify medicinal plants based on traditional practices to help develop a cure for PD. The three areas of study were chosen for their ecological and cultural diversities, and two of these are included in conservation programs (Panchase Protected Forest and Annapurna Conservation Area). The documentation of community–natural resource relationships is another step in the preservation of traditional practices and local biodiversity and a reflection of communities’ rights in the design of conservation programs.

Introduction

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease with 5% of the population being affected by age 85 (Dauer and Przedborski, 2003, Dawson and Dawson, 2003, Shulman et al., 2011). The disease involves a loss of dopaminergic neurons from the substantia nigra in the midbrain, and this loss of neurons is largely responsible for symptoms such as the inability to initiate movement, resting tremor and reduced balance (Massano and Bhatia, 2012). Pathological molecular events underlying neurodegeneration in PD include oxidative stress (Wang et al., 2006, Sanders and Timothy Greenamyre, 2013), loss of mitochondrial function (Betarbet et al., 2000, Banerjee et al., 2009, Youle and van der Bliek, 2012), aggregation of the pre-synaptic protein alpha-synuclein (Spillantini et al., 1997, Dawson et al., 2010, Rochet et al., 2012), and neuroinflammation (Block et al., 2007). Current therapeutic strategies for PD only alleviate symptoms and do not reverse the neuronal death (Jankovic and Poewe, 2012). Accordingly, we propose to use an ethnopharmacological approach to identify medicinal plants with the potential to lower the risk of PD and slow the disease progress.

Nepal is a hotspot of cultural and ecological diversity. This small country of 147,181 km² is located between India and China, two highly advanced centers of traditional medicine. Over the ages, Nepal has been influenced by these two cultural centers, and as a result traditional medicinal approaches in this country are now characterized by a unique blend of Ayurvedic, Tibetan and local folk medicines with their own unique evolutionary history (Phoboo et al., 2008). More than 80% of the Nepalese rural population depends on traditional medicine as the primary source of health care (Phoboo et al., 2008). Nepal has a tremendous plant diversity and displays a striking variation in microclimates and climates ranging from tropical to alpine over a distance of only 150 km (Bhattarai and Vetaas, 2003). Floristically, Nepal is a transition zone between the Western and Eastern Himalayas, thus providing a unique blend of plant species, a large number of which are endemic. A total of 118 ecosystems distributed across five physiographic zones were identified (Shengji, 1996), and more than 6000 vascular plants have been documented so far (about 1.5 times as many as in France) (Press et al., 2000). Furthermore, numerous communities with diverse cultural elements (e.g. 100 spoken dialects (Ghimire, 2008)) evolved independently in Nepal and developed a broad range of uses for medicinal plants. In this context, we studied three natural areas with distinct eco-geographical characteristics, namely the Panchase, Chitwan and Lower Mustang regions.

The Panchase region is located in the districts of Kaski, Parbat and Syangja and encompasses an area of 54.7 km². This region is characterized by subtropical and temperate vegetation and is a hotspot for biological diversity (Bhattarai et al., 2011). More than 589 flowering plant species have been documented in the Panchase region, and here the orchid diversity is exceptional. In the Panchase region, 113 species of orchids have been identified (27% of the orchid species identified in Nepal), out of which two are endemic (Panisea panchaseensis and Eria pokharensia) (Subedi et al., 2011, Kunwar and Acharya, 2013). The Panchase Protected Forest Program is a community-based project initiated to preserve the land, plant and wildlife biodiversity from overexploitation and degradation (Upadhyay, 2012). This report is the first documentation of local medicinal practices to treat PD in Panchase, and it complements ongoing conservation work in this area (Kunwar and Acharya, 2013). Our research highlights the relation of local communities with their natural resources, a critical process for the proper conservation of biodiversity in relation to indigenous rights (IUCN, 2004, Bajracharya et al., 2006).

The Chitwan district has a surface area of about 2218 km2 (Neupane and Shresta, 2009) and is located in the Indo-Gangetic plain of Nepal, or Terai (flat plains). The climate is subtropical, and there is heavy rainfall during the monsoon season, with an annual precipitation of 2214 mm recorded at Rampur station (Neupane and Shrestha, 2009). As a result, the vegetation in this region is characterized by deciduous tropical forests.

Lastly, the Mustang district is divided into the Lower and Upper Mustang regions and encompasses a region of 3,639 km². The Lower Mustang region spans an altitudinal range of 2000–3700 m and is characterized by an extreme bio-climatic gradient, from deciduous oak and pine forests to steppe formations (Fort, 1987). Overall, the Mustang district has a windy and dry climate with less than 200 mm of rain annually (NTNC, 2008). The Highlands of Nepal (>3000 m) are characterized by a reduced diversity of flora but a higher proportion of endemic species (MoFSC, 2002), and it is therefore critical to preserve and document local medicinal practices.

Diverse research strategies are needed to find a cure for PD. Nepal’s tremendous plant diversity and striking variation in climates and local culture provide a unique opportunity to obtain new insight into effective herbal remedies and to understand the role of vegetal and cultural environments in the evolution of medicinal practices. To capitalize on this opportunity, we conducted an ethnopharmacological study in which local people and traditional healers in the Panchase, Chitwan and Mustang regions were interviewed to document the use of local plants to treat PD-related symptoms. Our study revealed a number of candidate neuroprotective plant specimens that warrant further investigation in experimental models of PD and other disorders.

Section snippets

Study areas

This ethnobotanical study was carried out in five communities located in three different eco-geographical environments and in a range of altitudes from 300 m to 3700 m. The first area of study was located in the Jutpani Village Development Committee (VDC) in the Chitwan district (altitude 300 m). The second study area was located in the Bhadaure-Tamasi VDC (1500 m) of Kaski district in the Panchase region. The third study area was located in the lower region of Mustang district, where we

Medicinal uses of plants

We interviewed a total of 56 participants across the three research areas (Table 2). Supplementary Table A.1 reports the local uses of 35 different plant species along the Chitwan–Panchase–Mustang altitudinal range. The uses of the various parts of each plant are described along with the mode of preparation (additional information is available upon request). The medicines from these plants are most commonly prepared in the form of a paste, with little variation across the altitudinal range.

Conclusion

The objectives of this study were to (i) document the use of medicinal plants to treat symptoms related to PD in the Chitwan–Panchase–Mustang altitudinal range and (ii) use quantitative information to evaluate the influence of local Ayurvedic practice on local knowledge and medicine. We identified 33 species of medicinal plants used to treat symptoms related to PD and other disorders, and 8 of these were used in all three areas of study: Acacia catechu, Acorus calamus, Asparagus racemosus,

Acknowledgments

The authors would like to thank Dr. Djaja Soejarto, Dr. Shiva Adhikari, Sudip Khadra, Sangita Shakya and Bastien Jacquet for their valuable contribution to the preparation and achievement of this project, as well as all of the people and healers who participated in this study. This work was funded by the Botany in Action program, Phipps botanical garden, Pittsburgh.

References (103)

  • H. Kim et al.

    Anti-inflammatory activity of a water extract of Acorus calamus L. leaves on keratinocyte HaCaT cells

    J. Ethnopharmacol.

    (2009)
  • S.K. Kulkarni et al.

    Withania somnifera: an Indian ginseng

    Prog. Neuro-psychopharmacol. Biol. Psychiatry

    (2008)
  • L. Liu et al.

    beta-Asarone induces senescence in colorectal cancer cells by inducing lamin B1 expression

    Phytomed. Int. J. Phytother. Phytopharmacol.

    (2013)
  • D.E. Moerman

    Agreement and meaning: rethinking consensus analysis

    J. Ethnopharmacol.

    (2007)
  • E. Murillo-Rodriguez et al.

    Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats

    Life Sci.

    (2011)
  • M.H. Oh et al.

    Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity

    Phytomed. Int. J. Phytother. Phytopharmacol.

    (2004)
  • R. Ojha et al.

    Asparagus recemosus enhances memory and protects against amnesia in rodent models

    Brain Cogn.

    (2010)
  • B.C. Park et al.

    Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells

    Cancer Lett.

    (2005)
  • E.K. Perry et al.

    Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

    Brain Cogn.

    (1995)
  • J.C. Rochet et al.

    Molecular insights into Parkinson׳s disease

    Prog. Mol. Biol. Transl. Sci.

    (2012)
  • L.H. Sanders et al.

    Oxidative damage to macromolecules in human Parkinson disease and the rotenone model

    Free Radic. Biol. Med.

    (2013)
  • T. Sidiq et al.

    A novel sarsasapogenin glycoside from Asparagus racemosus elicits protective immune responses against HBsAg

    Immunol. Lett.

    (2011)
  • J. St-Pierre et al.

    Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

    Cell

    (2006)
  • R. Tarawneh et al.

    Potential future neuroprotective therapies for neurodegenerative disorders and stroke

    Clin. Geriatr. Med.

    (2010)
  • S.B. Vohora et al.

    Central nervous system studies on an ethanol extract of Acorus calamus rhizomes

    J. Ethnopharmacol.

    (1990)
  • A.B. West et al.

    To die or grow: Parkinson׳s disease and cancer

    Trends Neurosci.

    (2005)
  • C.L. Xu et al.

    Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax

    Pharmacol. Biochem. Behav.

    (2012)
  • N. Yoshimi et al.

    The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats

    Cancer Lett.

    (2001)
  • A. Agarwal et al.

    Effect of Tinospora cordifolia on learning and memory in normal and memory deficit rats

    Indian J. Pharmacol.

    (2002)
  • K.L. Bairt et al.

    Efficacy of Tinospora cordifolia on learning and memory in healthy volunteers: a double-blind, randomized, placebo controlled study

    Iran. J. Pharmacol. Ther.

    (2004)
  • S.B. Bajracharya et al.

    Impacts of community-based conservation on local communities in the Annapurna conservation area, Nepal

    Biodivers. Conserv.

    (2006)
  • S. Banerjee et al.

    Assessment of the anti-inflammatory effects of Swertia chirata in acute and chronic experimental models in male albino rats

    Indian J. Pharmacol.

    (2000)
  • R. Betarbet et al.

    Chronic systemic pesticide exposure reproduces features of Parkinson׳s disease

    Nat. Neurosci.

    (2000)
  • K.R. Bhattarai et al.

    Medicinal Plant Knowledge of the Panchase Region in the Middle Hills of the Nepalese Himalayas

    (2011)
  • K.R. Bhattarai et al.

    Variation in plant species richness of different life forms along a subtropical elevation gradient in the Himalayas, east Nepal

    Global Ecol. Biogeogr.

    (2003)
  • M.L. Block et al.

    Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

    Nat. Rev. Neurosci.

    (2007)
  • J. Bradwejn et al.

    A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects

    J. Clin. Psychopharmacol.

    (2000)
  • N.S. Brown et al.

    Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer

    Breast Cancer Res.

    (2001)
  • C.B. Carroll et al.

    Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

    Neurology

    (2004)
  • P.C. Chen et al.

    Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson׳s disease: critical role for the astrocyte

    Proc. Natl. Acad. Sci. U.S.A.

    (2009)
  • C.M. Clements et al.

    DJ-1, a cancer- and Parkinson׳s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

    Proc. Natl. Acad. Sci. U.S.A.

    (2006)
  • S.P. Close et al.

    Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson׳s disease

    Psychopharmacology

    (1990)
  • Y. Couch et al.

    The acute inflammatory response to intranigral alpha-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

    J. Neuroinflammation

    (2011)
  • T.M. Dawson et al.

    Molecular pathways of neurodegeneration in Parkinson׳s disease

    Science

    (2003)
  • M.J. Devine et al.

    Parkinson׳s disease and cancer: two wars, one front

    Nat. Rev. Cancer

    (2011)
  • D. Dhingra et al.

    Evidences for the involvement of monoaminergic and GABAergic systems in antidepressant-like activity of Tinospora cordifolia in mice

    Indian J. Pharm. Sci.

    (2008)
  • R.L. Doty

    Olfactory dysfunction in Parkinson disease.

    Nat. Rev. Neurol.

    (2012)
  • DPR

    Medicinal Plants of Nepal. Department of Plant Resources (DPR)

    (2007)
  • M. Fort

    Geomorphic and hazards mapping in the dry, continental Himalaya—1–50,000 maps of Mustang District, Nepal

    Mt. Res. Dev.

    (1987)
  • D. Garcia et al.

    Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses

    Phytother. Res.

    (2003)
  • Cited by (24)

    • Swertia chirayita: A comprehensive review on traditional uses, phytochemistry, quality assessment and pharmacology

      2023, Journal of Ethnopharmacology
      Citation Excerpt :

      Indigenous people utilized this medicinally important plant in a variety of ways. The whole plant directly or in decoction is traditionally used to cure inflammation, hepatitis, digestive disorders, fever, vomiting, persistent edema, intrinsic hemorrhage, liver diseases, heart diseases, gastrointestinal infection, headache, malaria, scorpion bite, skin diseases, hypotension, and blood sugar levels (Bhatt et al., 2006; Mukherji, 1953; Nadkarni and Nadkarni, 1976; Kirtikar and Basu, 1984; Schimmer and Mauthner, 1996; Joshi and Dhawan, 2005; De Rus Jacquet et al., 2014; Shah et al., 2014; Malla et al., 2015). Besides, numerous Ayurvedic formulations (Mahasudarshana churna, Chandra Prabati, Mensturyl syrup, Ayush-64, Diabecon, and Melicon V ointment) are commercially available where this plant is utilized solely or in combination with other herbs as an important ingredient (Edwin and Chungath, 1988; Mitra et al., 1996; Valecha et al., 2000).

    • Neuro-nutraceutical potential of Asparagus racemosus: A review

      2021, Neurochemistry International
      Citation Excerpt :

      Previous reports on A. racemosus have shown that Racemosol and Rhamnose, key components of A. racemosus, have neuroprotective properties against PD (Bagchi et al., 2017; Banjari et al., 2018). Moreover, A. racemosus based nutraceuticals also have the potential to treat rigidity of limbs, primary symptoms observed in PD patients (de Rus Jacquet et al., 2014) (Fig. 4). Later on, Smita et al. (2017) evaluated the effectiveness of shatavarin IV, a steroidal component of A. racemosus, in transgenic Caenorhabditis elegans model of aging and associated PD.

    • Neuroprotective effects of Bergenia ciliata on NMDA induced injury in SH-SY5Y cells and attenuation of cognitive deficits in scopolamine induced amnesia in rats

      2018, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      The plant consists of a concoction of bioactives like bergenin, gallic acid, catechin, tannic acid, β-sitosterol, stigmasterol, etc. belonging to the various classes of compounds like isocoumarins, polyphenols, phenolic acids, phytosterols, glycosides, etc. In Ayurvedic texts, the plant has been mentioned to be used for lithiasis and in the renal calculus disease [25]. The folk in the Chitwan region of Nepal use this plant to alleviate the symptoms associated with Parkinson’s disease and other CNS disorders owing to its anti-inflammatory, analgesic and stimulant effects [25].

    • Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms

      2017, Journal of Ethnopharmacology
      Citation Excerpt :

      Mental health conditions including anxiety and depression were of particular interest as medicines for treating these disorders likely cross the blood brain barrier (BBB) to target various regions of the brain, including the midbrain (Chaudhury et al., 2013). Information about herbal remedies used to treat cancers was also considered relevant based on evidence that pathogenic mechanisms such as inflammation, oxidative stress, and the dysregulation of certain key proteins are common to both PD and some cancers (de Rus Jacquet et al., 2014; Devine et al., 2011; West et al., 2005). When available, voucher specimens were collected, assigned a collection number, and deposited at the Purdue Kriebel Herbarium for future reference.

    View all citing articles on Scopus
    View full text